Skip to main content
SpringerLink
Log in

Mechanisms underlying and medical management of l-Dopa-associated motor complications

  • Editorial
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Boroojerdi B, Wolff HM, Braun M, Scheller DK (2010) Rotigotine transdermal patch for the treatment of Parkinson’s disease and restless legs syndrome. Drugs Today (Barc) 46(7):483–505

    Article  CAS  Google Scholar 

  • Chase TN (1998) The significance of continuous dopaminergic stimulation in the treatment of Parkinson’s disease. Drugs 55(S1):1–9

    Article  PubMed  Google Scholar 

  • Dekundy A, Gravius A, Hechenberger M, Pietraszek M, Nagel J, Tober C, van der Elst M, Mela F, Parsons CG, Danysz W (2011). Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia. J Neural Transm 118(12). doi:10.1007/s00702-010-0526-0

  • Gerlach M, Bartoszyk GD, Riederer P, Dean O, van den Buuse M (2011a) Role of dopamine D3 receptors and serotonin 5-HT1A receptors in levodopa-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. J Neural Transm 118(12). doi:10.1007/s00702-010-0571-8

  • Gerlach M, Beck J, Riederer P, van den Buuse M (2011b) Flibanserin attenuates l-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. J Neural Transm 118(12). doi:10.1007/s00702-010-0570-9

  • Grünblatt E, Schmidt WJ, Scheller DKA, Riederer P, Gerlach M (2011) Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats. J Neural Transm 118(12). doi: 10.1007/s00702-010-0552-y

  • Iravani MM, Jenner P (2011) Mechanisms underlying the onset and expression of levodopa induced dyskinesia and their pharmacological manipulation. J Neural Transm 118(12). doi:10.1007/s00702-011-0698-2

  • Jankovic JJ (2005) Motor fluctuations and dyskinesias in Parkinson’s disease: Clinical manifestations. Mov Disord 20(Suppl 11):S11–S16

    Article  PubMed  Google Scholar 

  • Jenner P, McCreary AC, Scheller DKA (2011) Continuous drug delivery in early and late stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression. J Neural Transm 118(12). doi:10.1007/s00702-011-0703-9

  • Müller T, Russ H (2006) Levodopa, motor fluctuations and dyskinesia in Parkinson’s disease. Expert Opin Pharmacol 7:1715–1730

    Article  Google Scholar 

  • Wolf E, Sepppi K, Katzenschlager R et al (2010) Long-term antidyskinetic efficacy of amantadine in Parkinson’s disease. Mov Disord 25:1357–1363

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Clinical Neurobiology, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Füchsleinstrasse 15, 97080, Würzburg, Germany

    Manfred Gerlach

  2. Laboratory for Clinical Neurochemistry, Department of Psychiatry, Psychosomatics and Psychotherapy, National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research, University of Würzburg, Füchsleinstrasse 15, 97080, Würzburg, Germany

    Peter Riederer

  3. Department Pharmacology of Parkinson’s Disease and Movement Disorders, CNS Research UCB Pharma S.A, Chemin Du Foriest, 1420, Braine l’Alleud, Belgium

    Dieter Scheller

Authors
  1. Manfred Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dieter Scheller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dieter Scheller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerlach, M., Riederer, P. & Scheller, D. Mechanisms underlying and medical management of l-Dopa-associated motor complications. J Neural Transm 118, 1659–1660 (2011). https://doi.org/10.1007/s00702-011-0728-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-011-0728-0

Search

Navigation